Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  La Jolla Pharmaceutical Company    

LA JOLLA PHARMACEUTICAL COMPANY
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

LA JOLLA PHARMACEUTICAL COMPANY : REVERSE SPLIT: 1 for 50

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2014 CET
REVERSE SPLIT: 1 for 50


© Factset 2014
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LA JOLLA PHARMACEUTICAL CO
01/30LA JOLLA PHARMACEUTICAL CO : Other Events (form 8-K)
AQ
01/25THURSDAY SECTOR LEADERS : Biotechnology, Defense Stocks
AQ
2017LA JOLLA PHARMACEUTICAL : Pharma Gets FDA Approval for Blood Pressure Drug
AQ
2017LA JOLLA PHARMACEUTICAL COMPANY (NAS : LJPC) Files An 8-K Other Events
AQ
2017LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (fo..
AQ
2017LA JOLLA PHARMACEUTICAL COMPANY : Announces FDA Approval of Giapreza
AQ
2017HERE’S WHAT’S MOVING LA : LJPC) And Biogen Inc. (NASDAQ:BIIB)
AQ
2017LA JOLLA PHARMACEUTICAL COMPANY : Announces FDA Approval of Giapreza (angiotensi..
AQ
2017LA JOLLA PHARMACEUTICAL : FDA approves La Jolla's distributive shock therapy
AQ
2017La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (an..
GL
More news
Financials ($)
Sales 2017 -
EBIT 2017 -105 M
Net income 2017 -105 M
Finance 2017 106 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 0
EV / Sales 2018 27,8x
Capitalization 730 M
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 6
Average target price 57,9 $
Spread / Average Target 76%
EPS Revisions
Managers
NameTitle
George Francis Tidmarsh President, CEO, Secretary & Director
Kevin C. Tang Chairman
Jennifer Carver Chief Operating Officer
Dennis M. Mulroy Chief Financial & Accounting Officers
Lakhmir S. Chawla Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
LA JOLLA PHARMACEUTICAL COMPANY725
GILEAD SCIENCES14.21%106 851
VERTEX PHARMACEUTICALS4.94%39 772
REGENERON PHARMACEUTICALS-12.04%35 529
BIOVERATIV INC91.99%11 201
GENMAB4.28%11 055